These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34861015)

  • 21. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of dolasetron in two oral liquid vehicles.
    Johnson CE; Wagner DS; Bussard WE
    Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of ampicillin trihydrate suspension in amber plastic oral syringes.
    Sylvestri MF; Makoid MC
    Am J Hosp Pharm; 1986 Jun; 43(6):1496-8. PubMed ID: 3728487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
    Pramann LA; Davidow LW; van Haandel L; Funk RS
    Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
    Coache D; Friciu M; Bernine Marcellin R; Bonnemain L; Viau A; Roullin VG; Forest JM; Leclair G
    PLoS One; 2022; 17(6):e0270206. PubMed ID: 35749410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of levetiracetam oral solution repackaged in oral plastic syringes.
    Prohotsky DL; Hughes SE; Zhao F
    Am J Health Syst Pharm; 2014 Feb; 71(3):219-22. PubMed ID: 24429015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of a pyrimethamine suspension compounded from bulk powder.
    Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
    Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome.
    Rochani A; Nguyen V; Becker R; Kraft W; Kaushal G
    J Pediatr Pharmacol Ther; 2021; 26(4):395-404. PubMed ID: 34035685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
    Winiarski AP; Infeld MH; Tscherne R; Bachynsky M; Rucki R; Nagano-Mate K
    J Am Pharm Assoc (2003); 2007; 47(6):747-55. PubMed ID: 18032138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of sumatriptan succinate in extemporaneously prepared oral liquids.
    Fish DN; Beall HD; Goodwin SD; Fox JL
    Am J Health Syst Pharm; 1997 Jul; 54(14):1619-22. PubMed ID: 9248606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term stability of atenolol in oral liquid formulations.
    Patel D; Doshi DH; Desai A
    Int J Pharm Compd; 1997; 1(6):437-9. PubMed ID: 23989440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of Vancomycin 25 mg/mL in Ora-Sweet and Water in Unit-Dose Cups and Plastic Bottles at 4°C and 25°C.
    Ensom MH; Decarie D; Lakhani A
    Can J Hosp Pharm; 2010 Sep; 63(5):366-72. PubMed ID: 22479004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of buffer and antioxidant on stability of a mercaptopurine suspension.
    Aliabadi HM; Romanick M; Desai S; Lavasanifar A
    Am J Health Syst Pharm; 2008 Mar; 65(5):441-7. PubMed ID: 18281736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.